Items where Author is " Mathuber Marlene"

Dömötör Orsolya and Mathuber Marlene and Kowol Christian R.: In vitro biodistribution studies on clinically approved FGFR inhibitors ponatinib, nintedanib, erlotinib and the investigational inhibitor KP2692.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 192. ISSN 0928-0987 (2024)

Pósa Vivien and Stefanelli Alessia and Nunes Julia H. Bormio and Hager Sonja and Mathuber Marlene and May Nóra Veronika and Berger Walter and Keppler Bernhard K. and Kowol Christian R. and Enyedy Éva Anna and Heffeter Petra: Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance.
CANCERS, 14 (18). Terjedelem: 27 p.-Azonosító: 4455. ISSN 2072-6694 (2022)

Bormio Nunes Julia H. and Hager Sonja and Mathuber Marlene and Pósa Vivien and Roller Alexander and Enyedy Éva Anna and Stefanelli Alessia and Berger Walter and Keppler Bernhard K. and Heffeter Petra and Kowol Christian R.: Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux.
JOURNAL OF MEDICINAL CHEMISTRY, 63. pp. 13719-13732. ISSN 0022-2623 (2020)

Mathuber Marlene and Schueffl Hemma and Dömötör Orsolya and Karnthaler Claudia and Enyedy Éva Anna and Heffeter Petra and Kowol Christian R.: Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs.
INORGANIC CHEMISTRY, 59 (23). pp. 17794-17810. ISSN 0020-1669 (2020)